Every DEF 14A that Picard Medical, Inc. (PMI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow PMI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PMI filings page.
Picard Medical, Inc. is asking stockholders to vote at an online annual meeting on July 17, 2026. Holders of 102,695,935 common shares as of June 26, 2026 may vote.
Key items include electing four directors, advisory votes on executive pay and how often that vote should occur, and ratifying MaloneBailey LLP as auditor for 2026. The Board also seeks authority to implement a reverse stock split between 1‑for‑15 and 1‑for‑50, with a proportional cut to authorized shares, to help address NYSE American listing standards.
Another proposal would create a new Class B common stock with 15,000,000 authorized shares, each carrying 20 votes, which could concentrate voting power if issued. The proxy notes NYSE American notices citing stockholders’ equity of about $3.8 million at December 31, 2025 and a stockholders’ deficit of about $(1.4) million at March 31, 2026, and references a compliance plan running through November 8, 2027.
Picard Medical, Inc. is asking shareholders at a virtual Special Meeting on March 10, 2026 to approve two corporate actions: an amendment to increase authorized common stock to 300,000,000 shares and stockholder approval to permit issuance in excess of 20% of outstanding shares under a purchase agreement with the Selling Stockholders to satisfy NYSE American Rule 713.
As of February 6, 2026, 73,701,176 shares were outstanding. The company disclosed an initial $15,000,000 note issuance under a facility permitting up to an additional $35,000,000, initial warrants to purchase 7,009,346 shares, and conversion-related issuances of 9,990,654 shares. The Board unanimously recommends votes FOR both proposals.
Picard Medical, Inc. is asking stockholders at a special virtual meeting on March 10, 2026 to approve an amendment to its Certificate of Incorporation to increase authorized capital stock from 180,000,000 to 330,000,000 shares, including an increase in authorized common stock from 150,000,000 to 300,000,000 shares. As of February 6, 2026, 73,701,176 shares of common stock were outstanding, with additional shares reserved for an equity incentive plan, warrants and senior secured notes. The board says the increase is intended to provide flexibility to meet existing share issuance obligations and to support future financing and strategic transactions, while noting potential dilution and anti-takeover effects. The board unanimously recommends voting in favor of the proposal.
Picard Medical, Inc. has scheduled a Special Meeting for October 10, 2025 at 8:00 p.m. Eastern Time. The filing reports ownership snapshots based on 73,701,176 outstanding shares as of September 26, 2025, and discloses specific beneficial ownership positions and voting controls for named holders, including Hunniwell Picard I, LLC and Gregory L. Segal's control over Sindex SSI Financing, LLC.
The proxy contains governance and compensation plan language: the Board (or an authorized Committee) serves as Plan Administrator for the Amended and Restated 2021 Equity Incentive Plan, which includes a Share Reserve of 18,000,000 shares to be issued from authorized and unissued or treasury shares. The Plan permits awards such as Options, Warrants, SARs, Restricted Stock, RSUs, cash and other consideration, and authorizes substitutions and anti-repricing provisions consistent with GAAP treatment.